We Read FDA's Register of Compounding Facilities. 43 of 100 Have Never Been Inspected.

If a compounded GLP-1 arrives at your door, some pharmacy made it, and you are entitled to know which one and whether anyone has ever walked through the building. For one half of the compounding market there is a federal answer, published and free. We pulled the whole register and went through it.

What the register is

FDA maintains a list of every facility registered under section 503B of the Food, Drug, and Cosmetic Act. These are outsourcing facilities, the larger compounders that make medication in batches. For each one it publishes the name, the city and state, the date it first registered, the date it most recently re-registered, and the date it was last inspected.^[1] As of the October 29, 2026 FDA list (pulled November 6), it held 100 facilities.

Forty-one of the ninety-eight have never been inspected

FDA does not bury this. The inspection column says, in plain words, “Not yet inspected”, and on the October 29, 2026 list it said it for 43 of the 100, or 43% of the register. That is the number most people would publish, and on its own it is misleading.

The distribution says something different

We checked how long each uninspected facility had been registered. Almost all of them are recent. Of the 43 never inspected as of that list, only seven have been on the register for three years or more, four of them by a few weeks, and none for five. The rest registered within the last three years, and 27 of the 43 within the last two.

Read the other way round, the register looks like an agency keeping up rather than one that has lost track. Of the 57 facilities inspected on that list, all 57 were last inspected in 2025 or 2026. None has gone more than two years since an inspector was there.

Where they are

On the October 29, 2026 list, the register concentrates in a handful of states: Texas (17), Florida (16), New Jersey (8) and California (8) hold almost half of it between them. That matters mainly because a facility’s state is the thing you can look up next.

How to use this as a buyer

1. Ask which pharmacy fills the prescription, by name. Most sellers we track do not publish this. An unnamed pharmacy is a finding in itself.
2. Look for that name on the federal register. If it is there, you can see when it registered and when it was last inspected.
3. If it is not there, ask which state board licenses it. That is the right follow-up, not an accusation, because 503A pharmacies belong to state boards.
4. Treat “not yet inspected” as context, not a verdict. On this register it usually means recently registered.

A few sellers hand you the name for step one, which leaves you to run steps two and three yourself. Oria Meds and JumpstartMD both name PerfectRx. Vitara RX names Manifest Pharmacy in South Carolina as its 503A partner, and TrueMe names CarePoint Infusion Pharmacy in Texas. Elara MD answers the question in its FAQ, where it names Strive Pharmacy in Gilbert, Arizona.

Smaller and regional practices do it too. RegenCen, a Michigan and Florida hormone practice, names Belmar in Colorado. Red Mountain Weight Loss sends prescriptions to Nationwide Compounding Rx in Scottsdale, VitaFusions IV ships from New Solutions Functional Wellness Pharmacy, and Meli Health names Rush Pharmacy.

Among newer sellers, BMI Doctors gives its compounding partner, Beaker Pharmacy, with a McKinney, Texas street address and phone number. Leanefy answers “Who is our partner Pharmacy?” with Integrity Compounding Pharmacy in Sandy Springs, Georgia. Male Excel names Anazao Health Corp. in Tampa. Ness lists four partners, Belmar, Strive, Epiq Scripts and Casa Pharma Rx, each with a phone number.

CAPO Health names The Pharmacy Hub in Miami as its partner pharmacy, with a street address and phone number. Dose lists the same pharmacy among its partners. ZestRx gives Strive Pharmacy’s Gilbert, Arizona address for its current pharmacy.

Some pharmacies sit on both sides of the line. Empower Pharmacy in Houston runs a 503A pharmacy and an FDA-registered 503B outsourcing facility, and makes compounded semaglutide and tirzepatide for clinics and telehealth sellers. So the register tells you about one of its two sites, and the label tells you which one made your vial.